BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160212
DTEND;VALUE=DATE:20160213
DTSTAMP:20260729T193105
CREATED:20151218T130515Z
LAST-MODIFIED:20160111T145935Z
UID:11956-1455235200-1455321599@ces.b2sg.org
SUMMARY:Grand Challenge Awards- Challenge 6:  Develop innovative approaches to target the cancer super-controller MYC
DESCRIPTION:Myc is a gene that is mutated and persistently switched on in the majority of human cancers – it’s a hallmark of the disease in nearly seven out of ten cases. \nMutant and overactive Myc helps tumours survive\, and this strongly suggests that blocking its function would be a powerful approach to treating many types of cancer. \nOf course\, Myc isn’t the only gene mutation that’s linked to cancer\, so why is this a Grand Challenge? It’s partly because the gene makes a protein (called MYC) that is a powerful ‘super controller’–a vital hub at the centre of a vast communication network within cells\, and the properties of the MYC protein itself make it really difficult to design a drug against it. \nThat’s why we’re putting out a call to the global research community – this challenge needs more than just money\, it needs new thinking\, innovation and a wide range of expertise.
URL:https://ces.b2sg.org/event/grand-challenge-awards-challenge-6-develop-innovative-approaches-to-target-the-cancer-super-controller-myc/
CATEGORIES:Awards
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/Cancer-research-UK1.png
END:VEVENT
END:VCALENDAR